Human IFIT3 Modulates IFIT1 RNA Binding Specificity and Protein Stability

Britney Johnson(Washington University in St. Louis), Gaya K. Amarasinghe(Washington University in St. Louis), James P. White(Washington University in St. Louis), Michael L. Gross(Washington University in St. Louis), Laura A. VanBlargan(Washington University in St. Louis), Pei‐Yong Shi(The University of Texas Medical Branch at Galveston), Jagat Adhikari(Washington University in St. Louis), Michael Diamond(Washington University in St. Louis), Chao Shan(Chinese Academy of Sciences), Wei Xü(Southern Medical University), Rong Zhang(Huazhong Agricultural University), Daisy W. Leung(Washington University in St. Louis)
Immunity
March 1, 2018
10.1016/j.immuni.2018.01.014
Cited by 131

Related Papers

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
|Nature|2020|2.1k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
Potently neutralizing and protective human antibodies against SARS-CoV-2
|Nature|2020|1.2k